Skip to main
CADL

Candel Therapeutics (CADL) Market Capitalization Overview

Market Cap: $313.47M as of Jan 9, 2026

$313.47M
$14.28M (4.77%)past month
As of Jan 9, 2026, Candel Therapeutics (CADL) has a market capitalization of $313.47M. Over the past 30 days, its market cap has increased by 21.43%, while in the last 12 months, it has increased by 1.06%.

Market capitalization represents the total value of Candel Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Candel Therapeutics (CADL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Candel Therapeutics (CADL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Candel Therapeutics (CADL) Market Cap History

DateMarket CapChange
Dec 1, 2025$245.95M-14.17%
Nov 3, 2025$286.56M-5.78%
Oct 1, 2025$304.12M-5.46%
Sep 2, 2025$321.69M-4.09%
Aug 1, 2025$335.41M+29.69%
Jul 1, 2025$258.63M-7.66%
Jun 2, 2025$280.08M+21.25%
May 1, 2025$230.99M-12.21%
Apr 1, 2025$263.11M-25.21%
Mar 3, 2025$351.81M+10.63%
Feb 3, 2025$317.99M-20.47%
Jan 2, 2025$399.84M+169.41%

Candel Therapeutics (CADL) End of Year Market Cap History

DateMarket CapChange
2026$313.47M+1.06%
2025$310.18M-19.65%
2024$386.05M+808.09%
2023$42.52M-17.80%
2022$51.73M-76.95%
2021$224.36M

FAQs About Candel Therapeutics (CADL) Market Cap

As of Jan 9, 2026, the market capitalization of Candel Therapeutics (CADL) is $313.47M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Candel Therapeutics’s market capitalization has increased by 4.77%, changing from $299.20M to $313.47M as of Jan 9, 2026.

In the last 3 months, Candel Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Candel Therapeutics’s market capitalization decreased from $386.05M in January to $310.18M in December, reflecting a -19.65% change.

In the past five years, Candel Therapeutics (CADL) has had a compound annual growth rate (CAGR) of 6.69% in market capitalization. This means its market cap has grown at an average rate of 6.69% per year.

Candel Therapeutics (CADL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.